Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy

Volume: 21, Issue: 1
Published: Mar 3, 2021
Abstract
Background Ductal adenocarcinoma of the pancreas (PDAC) remains one of the most lethal malignancies. To date, no guidelines exists for isolated resectable metachronous disease. It is still unknown, which patients may benefit from relapse surgery. The aim of our study was to compare disease free survival (DFS) and post relapse survival (PRS) in patients with isolated local recurrence, metachronous hepatic or pulmonary metastases. Methods Patients...
Paper Details
Title
Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy
Published Date
Mar 3, 2021
Volume
21
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.